AI assistant
Invesco Ltd. — Director's Dealing 2018
Jan 18, 2018
10507_dirs_2018-01-18_3502df61-9e87-4039-b93d-806255a57dc2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Evofem Biosciences, Inc. (EVFM)
CIK: 0001618835
Period of Report: 2018-01-17
Reporting Person: Invesco Ltd. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, Par value $0.0001 per share | 7037498 | Indirect |
Footnotes
F1: Invesco Ltd. is the beneficial owner of 7,037,498 shares of common stock acquired by its affiliates, Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund.
F2: Invesco Asset Management Ltd. is a subsidiary of Invesco Ltd., and it advises Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund
F3: As described in the Neothetics, Inc. Registration Statement on Form S-4 (File No. 333-221592), voting and investment power over the shares held by Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund is exercised by the directors of Invesco Asset Management Ltd. Neothetics, Inc. changed its name to Evofem Biosciences, Inc. on January 17, 2017.
F4: The common stock is directly owned by Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund.